| Literature DB >> 32222116 |
Daichi Morita1, Eizo Takahashi1, Masatomo Morita2, Makoto Ohnishi2, Tamaki Mizuno3, Shin-Ichi Miyoshi3, Devarati Dutta4, Thandavarayan Ramamurthy5, Goutam Chowdhury4, Asish K Mukhopadhyay4, Keinosuke Okamoto1.
Abstract
Non-O1/non-O139 nontoxigenic Vibrio cholerae associated with cholera-like diarrhea has been reported in Kolkata, India. However, the property involved in the pathogenicity of these strains has remained unclear. The character of 25 non-O1/non-O139 nontoxigenic V. cholerae isolated during 8 years from 2007 to 2014 in Kolkata was examined. Determination of the serogroup showed that the serogroups O6, O10, O35, O36, O39, and O70 were represented by two strains in each serogroup, and the remaining isolates belonged to different serogroups. To clarify the character of antibiotic resistance of these isolates, an antibiotic resistance test and the gene analysis were performed. According to antimicrobial drug susceptibility testing, 13 strains were classified as drug resistant. Among them, 10 strains were quinolone resistant and 6 of the 13 strains were resistant to more than three antibiotics. To define the genetic background of the antibiotic character of these strains, whole-genome sequences of these strains were determined. From the analysis of these sequences, it becomes clear that all quinolone resistance isolates have mutations in quinolone resistance-determining regions. Further research on the genome sequence showed that four strains possess Class 1 integrons in their genomes, and that three of the four integrons are found to be located in their genomic islands. These genomic islands are novel types. This indicates that various integrons containing drug resistance genes are spreading among V. cholerae non-O1/non-O139 strains through the action of newly generated genomic islands.Entities:
Keywords: Vibrio cholerae; antibiotic resistance; diarrhea; genome sequence; genomic island; integron
Year: 2020 PMID: 32222116 DOI: 10.1111/1348-0421.12790
Source DB: PubMed Journal: Microbiol Immunol ISSN: 0385-5600 Impact factor: 1.955